Scholarlink

<p>The updated European Society of Cardiology (ESC) guidelines on peripheral arterial and aortic diseases (PAAD) summarize comprehensive recommendations for the diagnostics, treatment and follow-up of these diseases of the arterial vascular system. For the first time PAAD are considered as a&#xa0;single entity that includes not only aortic diseases but also peripheral arterial occlusive disease of the lower extremities (PAOD) and stenoses and occlusions of the visceral and renal arteries, the brachial arteries and the extracranial vessels supplying the brain. Despite their high prevalence and considerable morbidity and mortality, these diseases often remain underdiagnosed and undertreated. Particular innovations include extended diagnostic recommendations and optimized drug treatment options, especially in the areas of antithrombotic treatment, lipid and blood pressure therapy and diabetes management. The guidelines also contain differentiated recommendations for action in interventional and surgical treatment, which are supplemented by new classification systems for individual risk stratification. A&#xa0;central focus is on a&#xa0;multidisciplinary care approach in specialized high-volume and competence centers. At the same time, shared decision-making with patients is emphasized in order to enable individually tailored treatment planning.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

DGK-Kommentar zu den Leitlinien der ESC (2024) zur Behandlung der peripheren arteriellen und aortalen Erkrankungen

  • 期刊论文

  • 发表日期：

    2025年8月20日

查看全文
  • Oliver J. Müller,
  • Johannes B. Dahm,
  • Christine Espinola-Klein,
  • Julia Lortz,
  • Christos Rammos,
  • Meike Rybczinsky,
  • Dierk Scheinert,
  • Christiane Tiefenbacher,
  • Axel Linke,
  • Uwe Raaz

摘要

The updated European Society of Cardiology (ESC) guidelines on peripheral arterial and aortic diseases (PAAD) summarize comprehensive recommendations for the diagnostics, treatment and follow-up of these diseases of the arterial vascular system. For the first time PAAD are considered as a single entity that includes not only aortic diseases but also peripheral arterial occlusive disease of the lower extremities (PAOD) and stenoses and occlusions of the visceral and renal arteries, the brachial arteries and the extracranial vessels supplying the brain. Despite their high prevalence and considerable morbidity and mortality, these diseases often remain underdiagnosed and undertreated. Particular innovations include extended diagnostic recommendations and optimized drug treatment options, especially in the areas of antithrombotic treatment, lipid and blood pressure therapy and diabetes management. The guidelines also contain differentiated recommendations for action in interventional and surgical treatment, which are supplemented by new classification systems for individual risk stratification. A central focus is on a multidisciplinary care approach in specialized high-volume and competence centers. At the same time, shared decision-making with patients is emphasized in order to enable individually tailored treatment planning.